Fundz

Synendos Therapeutics Appoints Dr George Garibaldi as Chief Medical Officer

PRIVATEJul 15, 2025

Position

Chief Medical Officer

Company

Synendos Therapeutics

George Garibaldi
SwitzerlandBiotechnologyHealth CareTherapeutics

Description

Synendos Therapeutics has appointed Dr George Garibaldi as its new chief medical officer. This strategic hiring aligns with the company's progression into Phase II clinical development of their key drug candidate SYT-510.

Quick answer

Synendos Therapeutics Appoints Dr George Garibaldi as Chief Medical Officer (July 15, 2025). Synendos Therapeutics is based in Switzerland.

Who is the new Chief Medical Officer at Synendos Therapeutics?
Synendos Therapeutics named George Garibaldi Chief Medical Officer, announced July 15, 2025.
What did Synendos Therapeutics announce on July 15, 2025?
Synendos Therapeutics has appointed Dr George Garibaldi as its new chief medical officer. This strategic hiring aligns with the company's progression into Phase II clinical development of their key drug candidate SYT-510.
What does Synendos Therapeutics do?
Synendos Therapeutics is a Swiss clinical-stage company specializing in the treatment of central nervous system (CNS) diseases.
Where is Synendos Therapeutics based?
Synendos Therapeutics is based in Switzerland.
Which similar companies made leadership changes around the same time?
Tract Bio (July 15, 2025), BrainXell (July 10, 2025), Jazz Pharmaceuticals plc (July 10, 2025) and CASI Pharmaceuticals (July 21, 2025) also announced leadership changes within 45 days of Synendos Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Synendos Therapeutics, and when

A new leader at Synendos Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Synendos Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Synendos Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Synendos Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Synendos Therapeutics

Location

Switzerland

About

Synendos Therapeutics is a Swiss clinical-stage company specializing in the treatment of central nervous system (CNS) diseases. The company is focused on advancing transformative neuroscience therapies. They are currently preparing for Phase II clinical development of their lead drug asset, SYT-510.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Synendos Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Synendos Therapeutics's next move

Learn about Strategic plan

Synendos Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.